Literature DB >> 1576827

Type 1 neurofibromatosis and the pediatric patient.

V M Riccardi1.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1576827     DOI： 10.1016/0045-9380(92)90053-2

Source DB:  PubMed          Journal:  Curr Probl Pediatr        ISSN： 0045-9380


× No keyword cloud information.
  18 in total

1.  High prevalence of elevated blood pressure among children with neurofibromatosis type 1.

Authors:  Tom Dubov; Hagit Toledano-Alhadef; Gil Chernin; Shlomi Constantini; Roxana Cleper; Shay Ben-Shachar
Journal:  Pediatr Nephrol       Date:  2015-08-28       Impact factor: 3.714

Review 2.  Spinal deformity in neurofibromatosis type-1: diagnosis and treatment.

Authors:  Athanasios I Tsirikos; Asif Saifuddin; M Hilali Noordeen
Journal:  Eur Spine J       Date:  2005-02-15       Impact factor: 3.134

3.  Ras protein/cAMP-dependent protein kinase signaling is negatively regulated by a deubiquitinating enzyme, Ubp3, in yeast.

Authors:  Yang Li; Yuqi Wang
Journal:  J Biol Chem       Date:  2013-03-08       Impact factor: 5.157

Review 4.  Treatments for astrocytic tumors in children: current and emerging strategies.

Authors:  Stanislaw R Burzynski
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

Review 5.  Clinical and genetic patterns of neurofibromatosis 1 and 2.

Authors:  N K Ragge
Journal:  Br J Ophthalmol       Date:  1993-10       Impact factor: 4.638

6.  Potential clinical role of FDG-PET in detecting sarcomatous transformation in von Recklinghausen's disease: a case study and review of the literature.

Authors:  Sandip Basu; Narendra Nair
Journal:  J Neurooncol       Date:  2006-07-19       Impact factor: 4.130

7.  Encephalocraniocutaneous lipomatosis with a mutation in the NF1 gene.

Authors:  E Legius; R Wu; M Eyssen; P Marynen; J P Fryns; J J Cassiman
Journal:  J Med Genet       Date:  1995-04       Impact factor: 6.318

8.  A genetic study of neurofibromatosis type 1 (NF1) in south-western Ontario. II. A PCR based approach to molecular and prenatal diagnosis using linkage.

Authors:  D I Rodenhiser; P J Ainsworth; M B Coulter-Mackie; S M Singh; J H Jung
Journal:  J Med Genet       Date:  1993-05       Impact factor: 6.318

9.  Neurofibromatosis presenting as a severe systemic vasculopathy.

Authors:  T Lehrnbecher; A M Gassel; V Rauh; T Kirchner; H I Huppertz
Journal:  Eur J Pediatr       Date:  1994-02       Impact factor: 3.183

10.  Infantile spasms in patients with neurofibromatosis type 1.

Authors:  A Fois; A Tiné; L Pavone
Journal:  Childs Nerv Syst       Date:  1994-04       Impact factor: 1.475
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.